About this trial
This registry trial is designed to track the local control rates and side effects of IORT, which will be implemented for women who are suitable partial breast irradiation (PBI) per the latest American Society of Radiation Oncology (ASTRO) guidelines.
Eligibility criteria
Qualifiers
Female gender
Age ≥ 45
cT1-2N0, <3.5cm invasive breast cancer, estrogen-receptor positive or DCIS of breast, Grade 1-2, mammographically detected, < 2.5 cm, estrogen-receptor positive
Suitable for breast conserving surgery
Disqualifiers
Known axillary lymph node positive breast cancer (negative biopsy not required)
Multicentric cancer in the same breast as diagnosed by clinical examination, mammography, ultrasound, MRI or pathologic assessment, not amenable to excision with negative margins with a single lumpectomy.
Patients known to have BRCA 1/2 (breast cancer 1, breast cancer 2) gene
Patients undergoing neoadjuvant chemotherapy
Trial design
Treatments tested in this trial
- Not listed